Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2019-08-20
CRTXCortexyme, Inc.Epiq Capital Group, LLCIA/Managing Member 10% ownerP - Purchase$25.35+4,9658,497,6830%+$125,863
D
2019-08-19
NSTGNanostring Technologies IncGhesquiere David W.SVP, Corporate, Business DevS - Sale+OE$28.23-18,42151,822-26%-$520,113
AD
2019-06-05
NSTGNanostring Technologies IncGhesquiere David W.SVP, Corporate, Business DevS - Sale+OE$29.41-6,95451,822-12%-$204,493
2019-08-20
INMBInmune Bio, Inc.Moss David JCFO, Treasurer, Secretary, 10%P - Purchase$5.65+3,0001,223,4170%+$16,950
2019-08-20
INMBInmune Bio, Inc.Tesi Raymond JosephPres, CEO, 10%P - Purchase$5.99+2,0001,540,9330%+$11,987
2019-08-19
ALECAlector, Inc.King RobertChief Development OfficerS - Sale$15.00-7,500529,817-1%-$112,500
M
2019-08-19
ALECAlector, Inc.Paul RobertChief Medical OfficerS - Sale$16.00-2,000321,719-1%-$32,000
D
2019-08-19
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale+OE$37.55-15,000246,000-6%-$563,243
D
2019-08-20
BLUEBluebird Bio, Inc.Walsh Jeffrey T.Chief Strategy OfficerS - Sale+OE$124.00-50040,921-1%-$62,000
2019-08-19
CHRSCoherus Biosciences, Inc.Viret Jean-FredericCFOS - Sale$19.04-3,0008,513-26%-$57,120
2019-08-19
EDITEditas Medicine, Inc.Collins CynthiaCEOS - Sale$25.83-5,19311,373-31%-$134,135
M
2019-08-16
AERIAerie Pharmaceuticals IncForesite Capital Management Ii, LLC10%P - Purchase$23.88+153,8472,204,324+8%+$3,673,289
DM
2019-08-16
TWSTTwist Bioscience CorpThorburn James MCFOS - Sale+OE$29.81-10,00039,002-20%-$298,107
2019-08-12
MGTXMeiragtx Holdings PlcPerceptive Advisors LLCDir, 10%P - Purchase$23.50+425,5316,433,277+7%+$9,999,979
2019-08-16
CASICasi Pharmaceuticals, Inc.He Wei-WuCEO, 10%P - Purchase$3.20+20,0006,226,6230%+$64,000
2019-08-19
ASRTAssertio Therapeutics, IncHiggins Arthur JDir, Pres, CEOP - Purchase$1.61+25,000265,879+10%+$40,243
2019-08-19
GILDGilead Sciences IncPletcher Brett AEVP, GC, Corp SecS - Sale$64.35-60827,198-2%-$39,123
2019-08-16
ONVOOrganovo Holdings, Inc.Hughes Steven GeorgeChief Medical OfficerS - Sale$0.29-22,230138,484-14%-$6,431
2019-08-15
ALECAlector, Inc.Paul RobertChief Medical OfficerS - Sale$14.19-10,000323,719-3%-$141,900
M
2019-08-16
CRTXCortexyme, Inc.Epiq Capital Group, LLCIA/Managing Member 10% ownerP - Purchase$26.46+2,8002,829,5960%+$74,100
M
2019-08-14
JNCEJounce Therapeutics, Inc.Cole Hugh MChief Business OfficerS - Sale$3.99-2,33636,214-6%-$9,330
M
2019-08-14
JNCEJounce Therapeutics, Inc.Trehu ElizabethChief Medical OfficerS - Sale$3.99-2,33659,189-4%-$9,330
M
2019-08-14
JNCEJounce Therapeutics, Inc.Drapkin Kimberlee CCFO, TreasurerS - Sale$3.99-2,33647,014-5%-$9,330
D
2019-08-14
CHRSCoherus Biosciences, Inc.Anicetti Vincent RCOOS - Sale+OE$19.00-2,50019,310-11%-$47,500
D
2019-08-14
VCELVericel CorpMichel Gerard JCFO, VP, Corp. DevelopmentS - Sale+OE$16.62-17,000123,182-12%-$282,547
M
2019-08-13
LCTXLineage Cell Therapeutics, Inc.Broadwood Partners, L.P.Dir, 10%P - Purchase$0.98+24,55368,073,6660%+$24,045
2019-08-14
CASICasi Pharmaceuticals, Inc.He Wei-WuCEO, 10%P - Purchase$3.17+160,0006,206,623+3%+$507,200
D
2019-08-13
LCTXLineage Cell Therapeutics, Inc.Leavitt Chase C.GC, SecretaryP - Purchase$1.02+5,0005,000New+$5,100
2019-08-13
LCTXLineage Cell Therapeutics, Inc.Roberts BrandiCFO, SVP, FinanceP - Purchase$1.01+5,0005,000New+$5,050
2019-08-13
LCTXLineage Cell Therapeutics, Inc.Culley Brian MPres, CEOP - Purchase$1.01+10,00084,531+13%+$10,100
M
2019-08-12
AERIAerie Pharmaceuticals IncForesite Capital Management Ii, LLC10%P - Purchase$24.73+539,5552,050,477+36%+$13,341,170
D
2019-08-12
BOLDAudentes Therapeutics, Inc.Patterson Matthew RCEOS - Sale+OE$34.04-20,000287,182-7%-$680,835
DM
2019-08-12
DYAIDyadic International IncTchelet RonenVP of Research, Bus. DvlpmtS - Sale+OE$5.74-10,0000-100%-$57,389
AD
2019-05-13
NSTGNanostring Technologies IncGray R BradleyPres, CEOS - Sale+OE$26.59-50,00049,905-50%-$1,329,421
D
2019-08-12
NSTGNanostring Technologies IncGray R BradleyPres, CEOS - Sale+OE$24.84-40,00049,905-44%-$993,706
D
2019-08-13
NSTGNanostring Technologies IncMalloy KirkDirS - Sale+OE$25.05-1,0000-100%-$25,051
D
2019-08-13
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale+OE$11.93-2,778512,797-1%-$33,142
2019-08-12
MNTAMomenta Pharmaceuticals IncBeltramello Jo AnnChief HR, Inf. OfficerS - Sale$11.64-53369,290-1%-$6,204
2019-08-12
MNTAMomenta Pharmaceuticals IncManning Anthony M.Chief Scientific OfficerS - Sale$11.64-1147,390-2%-$1,327
2019-08-12
MNTAMomenta Pharmaceuticals IncFier IanChief Mfg, Program OfficerS - Sale$11.64-3545,015-7%-$4,121
2019-08-12
MNTAMomenta Pharmaceuticals IncKwon YoungSVP, Chief Business OfficerS - Sale$11.64-533100,819-1%-$6,204
2019-08-12
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale$11.74-1,773509,4030%-$20,815
A
2019-08-08
MNTAMomenta Pharmaceuticals IncBeltramello Jo AnnChief HR, Inf. OfficerS - Sale$11.67-60869,823-1%-$7,095
A
2019-08-08
MNTAMomenta Pharmaceuticals IncManning Anthony M.Chief Scientific OfficerS - Sale$11.67-2267,504-3%-$2,637
A
2019-08-08
MNTAMomenta Pharmaceuticals IncFier IanChief Mfg, Program OfficerS - Sale$11.67-2155,369-4%-$2,509
A
2019-08-08
MNTAMomenta Pharmaceuticals IncKwon YoungSVP, Chief Business OfficerS - Sale$11.67-636101,352-1%-$7,422
2019-08-12
ASRTAssertio Therapeutics, IncHiggins Arthur JDir, Pres, CEOP - Purchase$1.54+50,000240,879+26%+$76,900
2019-08-09
INMBInmune Bio, Inc.Tesi Raymond JosephPres, CEO, 10%P - Purchase$7.03+2,0001,538,9330%+$14,058
2019-08-09
XLRNAcceleron Pharma IncVeness Adam MVP, GC, Sec.S - Sale$45.00-3,26816,925-16%-$147,060
D
2019-08-08
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale+OE$124.03-95030,092-3%-$117,824
2019-08-09
TCONTracon Pharmaceuticals, Inc.Theuer CharlesPres, CEOP - Purchase$0.45+50,000173,565+40%+$22,500
2019-08-07
ALECAlector, Inc.Orbimed Advisors LLC10%S - Sale$17.90-650,0003,171,804-17%-$11,635,000
2019-08-07
DNLIDenali Therapeutics Inc.Schuth Alexander O.COO, SecretaryS - Sale$18.81-7,500634,631-1%-$141,075
D
2019-08-08
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$76.52-20,149746,294-3%-$1,541,827
D
2019-08-08
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale+OE$11.72-2,601511,176-1%-$30,484
D
2019-08-08
MNTAMomenta Pharmaceuticals IncKwon YoungSVP, Chief Business OfficerS - Sale+OE$11.82-626101,362-1%-$7,399
D
2019-08-08
MNTAMomenta Pharmaceuticals IncFier IanChief Mfg, Program OfficerS - Sale+OE$11.82-2105,374-4%-$2,482
D
2019-08-08
MNTAMomenta Pharmaceuticals IncManning Anthony M.Chief Scientific OfficerS - Sale+OE$11.82-2217,509-3%-$2,612
D
2019-08-08
MNTAMomenta Pharmaceuticals IncBeltramello Jo AnnChief HR, Inf. OfficerS - Sale+OE$11.82-59869,833-1%-$7,068
D
2019-08-07
TECHBio-Techne CorpBaumgartner Robert VDirP - Purchase$191.06+5008,726+6%+$95,530
DM
2019-08-06
NBIXNeurocrine Biosciences IncGorman Kevin CharlesCEOS - Sale+OE$95.31-80,000417,597-16%-$7,624,975
2019-08-07
AMGNAmgen IncWilliams R SandersDirS - Sale$183.04-4255,838-7%-$77,792
D
2019-08-07
AMGNAmgen IncSugar Ronald DDirS - Sale+OE$183.04-2,00014,336-12%-$366,080
2019-08-06
SGENSeattle Genetics Inc /waLiu Jean IGC, EVP, Leg AffairsS - Sale$75.00-3,71670,633-5%-$278,700
D
2019-08-06
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale+OE$116.08-5,06031,616-14%-$587,389
D
2019-08-06
NSTGNanostring Technologies IncBailey K ThomasCFOS - Sale+OE$25.24-35,6250-100%-$899,026
2019-08-07
BIEIPremier Biomedical IncFelder Mitchell SCOB, 10%P - Purchase$0.01+1,000,0001,328,031+305%+$7,300
2019-08-06
ADAPAdaptimmune Therapeutics PlcAmado RafaelPres, R, DS - Sale$2.06-11,04317,237-39%-$22,749
D
2019-08-05
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale+OE$116.93-85030,342-3%-$99,393
D
2019-08-02
BCDABiocardia, Inc.Stertzer Simon HDir, 10%P - Purchase$6.00+166,6661,003,083+20%+$999,996
2019-08-03
HALOHalozyme Therapeutics, Inc.Chondros DimitriosSVP, Chief Medical OfficerS - Sale$16.70-1,32838,584-3%-$22,178
M
2019-08-01
AXLAAxcella Health Inc.Epstein David RDirP - Purchase$7.00+6,94138,293+22%+$48,619
M
2019-07-31
FATEFate Therapeutics IncNashat AmirDirS - Sale$22.53-62,00511,034-85%-$1,397,066
2019-07-30
NBIXNeurocrine Biosciences IncLyons Gary ADirS - Sale$92.07-10,000235,697-4%-$920,686
D
2019-07-30
NBIXNeurocrine Biosciences IncLippoldt DarinGCS - Sale+OE$92.13-15,83119,961-44%-$1,458,569
D
2019-07-30
NBIXNeurocrine Biosciences IncGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$92.92-60,000108,408-36%-$5,575,438
D
2019-07-30
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$92.77-44,356141,976-24%-$4,114,858
M
2019-07-26
FATEFate Therapeutics IncNashat AmirDirS - Sale$22.51-118,33311,635-91%-$2,663,115
DM
2019-07-26
ALLOAllogene Therapeutics, Inc.Moore AlisonChief Technical OfficerS - Sale+OE$29.44-48,82765,373-43%-$1,437,603
2019-07-25
SLDBSolid Biosciences Inc.Perceptive Advisors LLCDir, 10%P - Purchase$4.65+2,822,5816,749,803+72%+$13,125,002
D
2019-07-23
GILDGilead Sciences IncPletcher Brett AEVP, GC, Corp SecS - Sale+OE$65.07-7,20027,198-21%-$468,504
M
2019-07-23
FATEFate Therapeutics IncNashat AmirDirS - Sale$22.51-81,89912,781-87%-$1,843,151
D
2019-07-19
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale+OE$49.49-15,000246,000-6%-$742,311
2019-07-19
AVROAvrobio, Inc.Atlas Venture Fund X, L.P.10%P - Purchase$18.50+810,8115,567,289+17%+$15,000,004
2019-07-19
AVROAvrobio, Inc.Booth BruceDirP - Purchase$18.50+810,8115,567,289+17%+$15,000,004
M
2019-07-18
FATEFate Therapeutics IncNashat AmirDirS - Sale$22.52-71,16613,574-84%-$1,602,506
DM
2019-07-18
RGNXRegenxbio Inc.Christmas Patrick J.SVP, GCS - Sale+OE$50.03-5,0003,058-62%-$250,147
D
2019-07-17
SGENSeattle Genetics Inc /waGryska David WDirS - Sale+OE$75.00-5,00048,013-9%-$375,000
2019-07-17
AXLAAxcella Health Inc.Epstein David RDirP - Purchase$7.55+1,00031,352+3%+$7,550
D
2019-07-15
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$87.50-30,680141,976-18%-$2,684,506
2019-07-15
NBIXNeurocrine Biosciences IncBenevich EricChief Commercial OfficerS - Sale$87.44-5,83514,910-28%-$510,201
2019-07-16
XLRNAcceleron Pharma IncVeness Adam MVP, GC, Sec.S - Sale$40.71-53820,193-3%-$21,902
D
2019-07-15
VCELVericel CorpMichel Gerard JCFO, VP, Corp. DevelopmentS - Sale+OE$19.68-17,000123,182-12%-$334,579
D
2019-07-15
RUBYRubius Therapeutics, Inc.Langer RobertDirS - Sale+OE$14.94-7,5000-100%-$112,049
D
2019-07-15
CHRSCoherus Biosciences, Inc.Anicetti Vincent RCOOS - Sale+OE$19.20-2,50019,310-11%-$48,000
D
2019-07-10
TECHBio-Techne CorpKummeth Charles R.CEOS - Sale+OE$213.12-16,96992,176-16%-$3,616,428
DM
2019-07-10
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$87.63-7,220141,976-5%-$632,717
DM
2019-07-10
CRSPCrispr Therapeutics AGKlein Lawrence OttoChief Business OfficerS - Sale+OE$50.02-20,00020,000-50%-$1,000,353
2019-07-10
CRSPCrispr Therapeutics AGNovak RodgerPresS - Sale$50.00-50,000848,007-6%-$2,500,065
M
2019-07-08
AXLAAxcella Health Inc.Epstein David RDirP - Purchase$8.24+5,79630,352+24%+$47,743
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top